Elsevier

The Lancet

Volume 310, Issue 8039, 24 September 1977, Pages 632-635
The Lancet

DEATH FROM ACUTE PANCREATITIS: M.R.C. Multicentre Trial of Glucagon and Aprotinin

https://doi.org/10.1016/S0140-6736(77)92499-0Get rights and content

Abstract

The influence of glucagon and aprotinin ('Trasylol') on the death-rate of acute pancreatitis has been studied in a randomised double-blind multicentre trial. The death-rate in 257 patients was 11%. In the doses used neither drug was found to diminish the risk of death.

References (7)

  • J.H.C. Ranson et al.

    J. surg. Res.

    (1977)
  • G. Proud et al.

    Lancet

    (1976)
  • J.E. Trapnell et al.

    Br. J. Surg.

    (1974)
There are more references available in the full text version of this article.

Cited by (129)

  • Pharmacological interventions for acute pancreatitis

    2017, Cochrane Database of Systematic Reviews
View all citing articles on Scopus
View full text